The FDA announced on July 18, 2024, that MAIN PRODUCTS INC is recalling Umary Acido Hialuronico supplements due to undeclared Diclofenac and Omeprazole. The agency states the product was marketed without an approved New Drug Application or Abbreviated New Drug Application.
How to tell if you have it
- Brand: MAIN PRODUCTS INC
- Product: Umary Acido Hialuronico, Suplemento Alimenticio, 850 mg caplets
- Packaging: 30-count bottles
- Lots: All lots within expiry
The hazard
FDA analysis found the product to be tainted with undeclared Diclofenac and Omeprazole. The agency classified this as a Class I recall, indicating a high risk of adverse health consequences.
Context
GovInfoNow's records show other recent recalls of similar products include Buy-Herbal Kian Pee Wan Capsules Recall (2026-03-21) and StuffbyNainax MR 7 SUPER 700000 Capsules (2025-12-15). Xyvona (Levorphanol) 2mg Tablet Recall occurred on 2026-05-22.